Strategic Plan for Herpes Research Includes Vaccines

In COVID-19, Latest News by Precision Vaccinations

To advance the clinical research into herpes simplex virus (HSV) infections, the U.S. National Institutes of Health (NIH) today released the Strategic Plan for HSV.
An NIH-wide HSV Working Group was formed in October 2022 to develop this plan, informed by feedback from more than 100 representatives of the research and advocacy communities and stakeholders.

Read More